Ocular Therapeutix's market cap is currently ―. The company's EPS TTM is $-1.256; its P/E ratio is -6.21; Ocular Therapeutix is scheduled to report earnings on May 10, 2024, and the estimated EPS forecast is $-0.19. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 14.80M	$ 15.08M	$ 15.19M	$ 13.37M	$ 14.08M
Gross Profit	$ 13.42M	$ 13.70M	$ 13.88M	$ 12.16M	$ 13.06M
EBIT	$ -25.07M	$ 2.91M	$ -18.69M	$ -28.55M	$ -15.25M
EBITDA	$ -22.56M	-	$ -16.79M	$ -26.84M	$ -13.52M
Net Income Common Stockholders	$ -29.22M	$ -516.00K	$ -20.68M	$ -30.32M	$ -15.54M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 195.81M	$ 110.55M	$ 66.61M	$ 79.03M	$ 102.30M
Total Assets	$ 252.06M	$ 162.38M	$ 122.56M	$ 128.57M	$ 149.29M
Total Debt	$ 83.39M	$ 83.02M	$ 64.77M	$ 64.61M	$ 64.28M
Net Debt	$ -112.42M	$ -27.53M	$ -1.84M	$ -14.41M	$ -38.02M
Total Liabilities	$ 160.93M	$ 154.53M	$ 119.47M	$ 118.86M	$ 113.91M
Stockholders Equity	$ 91.13M	$ 7.85M	$ 3.09M	$ 9.71M	$ 35.38M
Cash Flow	-
Free Cash Flow	$ -22.91M	-	$ -22.07M	$ -23.35M	$ -19.11M
Operating Cash Flow	$ -22.45M	$ -7.73M	$ -20.07M	$ -19.97M	$ -16.96M
Investing Cash Flow	$ -459.00K	$ -259.00K	$ -1.99M	$ -3.38M	$ -2.15M
Financing Cash Flow	$ 108.17M	$ 51.94M	$ 9.64M	$ 78.00K	$ 458.00K

Currency in USD

Ocular Therapeutix Earnings and Revenue History

Income Statement >

Ocular Therapeutix Debt to Assets

Balance Sheet >

Ocular Therapeutix Cash Flow

Cash Flow >

Ocular Therapeutix Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing